# European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

Study · id `cardio:ct-nct01087723` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01087723](<https://clinicaltrials.gov/study/NCT01087723>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01087723

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2198 participants.

## Technical summary

Registry record NCT01087723. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2016-02-12.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2198 participants (enrolled count; ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Primary completion: 2013-08 (actual) (ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Completion: 2014-08 (actual) (ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Results first posted: 2016-02-12 (ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Countries: Austria; Czechia; Denmark; France; Germany; Italy; Netherlands; Poland; Slovenia (ClinicalTrials.gov record NCT01087723, source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01087723-2016-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
- Acronym: EUROMAX
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Bivalirudin
- Intervention (Drug): Heparin
- Lead sponsor: The Medicines Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Bivalirudin (`cardio:bivalirudin`)
- Registry intervention name matches this record: Heparin (`cardio:heparin`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: The Medicines Company (`cardio:org-the-medicines-company`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bivalirudin started during emergency transport for primary PCI (`cardio:pubmed-24171490`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial (`cardio:pubmed-26056249`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial (`cardio:pubmed-26995053`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial (`cardio:pubmed-28273285`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c7d3222d4ecb5b057bbaf58501ea784220960e6422ca5c0b56b3028be1f0f731
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
